Designed to serve as consistent references in a concise manner, the IMF’s Tip Cards cover key topics, including treatment and care issues of interest to patients and caregivers. All of the Tip cards below can be downloaded, free of charge.
April 29, 2021
Abecma® (idecabtagene vicleucel, “ide-cel”) is the first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen…
January 18, 2018
This Tip Card covers the importance of treatment adherence.
February 01, 2019
When confronted with a diagnosis of multiple myeloma, consult with a myeloma specialist about treatment options.
January 28, 2021
Blenrep (belantamab mafodotin-blmf) is an antibody-drug conjugate (ADC), the first in a new class of treatments for myeloma. Blenrep is the…
October 08, 2020
Darzalex® (daratumumab) is the first FDA-approved monoclonal antibody that targets the CD38 protein on the surface of myeloma cells. The original…
We Thank Our Sponsors:
Amgen, GSK, Janssen, Karyopharm Therapeutics, Oncopeptides, Inc. and Takeda